Why the Australia and New Zealand PCR Systems Market Is Expanding Rapidly
The Australia and New Zealand PCR Systems Market is experiencing robust growth as polymerase chain reaction (PCR) technologies become indispensable across clinical diagnostics, biomedical research, pharmaceutical development, and environmental testing. PCR has evolved from a basic molecular biology tool into a core technology enabling disease detection, genetic analysis, and precision medicine.
The COVID-19 pandemic significantly accelerated PCR adoption in both Australia and New Zealand, strengthening laboratory infrastructure and increasing awareness of molecular diagnostics. Beyond infectious disease testing, PCR systems are now widely used in oncology diagnostics, genetic sequencing, pharmacogenomics, food safety, and environmental monitoring.
In 2025, the Australia and New Zealand PCR systems market was valued at USD 121.19 million. Supported by expanding healthcare investments, rising research funding, and continuous technological innovation, the market is expected to grow at a CAGR of 8.40% from 2026 to 2035, reaching USD 271.49 million by 2035.
Australia and New Zealand PCR Systems Market Overview
PCR systems are molecular diagnostic platforms used to amplify and analyze DNA and RNA sequences with high sensitivity and specificity. These systems consist of instruments, reagents, consumables, software, and supporting services, enabling a wide range of applications from diagnostics to advanced genomics research.
Key Market Snapshot
Market Value (2025): USD 121.19 Million
Forecast Value (2035): USD 271.49 Million
CAGR (2026–2035): 8.40%
Key Growth Areas: Real-time PCR, digital PCR, diagnostics
Major Countries: Australia, New Zealand
Australia and New Zealand benefit from well-developed healthcare systems, strong academic research networks, and supportive government policies, making the region a high-potential PCR market.
Key Growth Drivers of the Australia and New Zealand PCR Systems Market
1. Increasing Use of PCR in Clinical Diagnostics
PCR has become a gold standard for diagnosing:
Infectious diseases
Genetic disorders
Cancer biomarkers
Hospitals and diagnostic centers across Australia and New Zealand increasingly rely on real-time PCR and RT-PCR for accurate, rapid, and scalable testing.
2. Expansion of Genomics and Molecular Research
Government-funded research programs and university-led genomics initiatives are driving demand for advanced PCR systems. PCR is foundational for:
Gene expression analysis
Genotyping and sequencing workflows
Functional genomics research
Australia’s investment in precision medicine and genomics infrastructure is a major growth catalyst.
3. Growth of Pharmaceutical and Biotechnology Industries
PCR systems are widely used in pharma and biotech for:
Drug discovery and development
Clinical trial validation
Companion diagnostics
As biologics, cell therapies, and gene therapies gain momentum, the need for high-precision PCR platforms continues to rise.
4. Technological Advancements in PCR Techniques
The market is benefiting from innovations such as:
Digital PCR for absolute quantification
Multiplex PCR for simultaneous target detection
Hot-start PCR for improved specificity
These advancements improve sensitivity, reduce errors, and expand PCR’s application scope.
Key Trends Shaping the Australia and New Zealand PCR Systems Market
1. Shift Toward Real-Time and Digital PCR
Real-time PCR dominates due to its speed and quantitative accuracy, while digital PCR is gaining traction for:
Rare mutation detection
Oncology and liquid biopsy research
High-precision quantification
2. Growing Demand for Integrated PCR Solutions
Laboratories increasingly prefer end-to-end PCR solutions that combine:
Instruments
Reagents and consumables
Software and analytics
This trend enhances workflow efficiency and data reliability.
3. Expansion of PCR Beyond Healthcare
PCR systems are increasingly used in:
Environmental testing
Food safety and quality control
Agricultural biotechnology
This diversification supports long-term market sustainability.
Australia and New Zealand PCR Systems Market Segmentation Analysis
By Product
Reagents and Consumables
Largest revenue-generating segment
Includes primers, probes, enzymes, and kits
High recurring demand across applications
Instruments
PCR thermal cyclers
Real-time and digital PCR systems
Increasing adoption of compact and automated platforms
Software and Services
Data analysis and interpretation tools
Workflow automation and system maintenance
Growing importance in advanced diagnostics
By Technique
Conventional PCR: Used in basic research and education
Real-time PCR: Dominant technique in diagnostics
Digital PCR: Fastest-growing segment
Reverse Transcription PCR: Essential for RNA analysis
Hot-start PCR: Improved specificity and sensitivity
Multiplex PCR: Efficient multi-target detection
Other PCR Techniques: Niche and emerging applications
By Application
Gene Expression Analysis: Widely used in research
Genetic Sequencing: PCR as a preparatory step
Genotyping: Pharmacogenomics and population studies
Nucleic Acid Detection: Infectious disease testing
Nucleic Acid Synthesis: Research and synthetic biology
Standard Validation/Verification: Quality control
Diagnostic Applications: Largest application segment
Environmental Applications: Growing use in water and soil testing
Others: Agriculture and forensic science
By End User
Hospitals and Diagnostic Centres: Largest end-user segment
Healthcare Industries: Diagnostic service providers
Academia and Government Organisations: Strong research demand
Pharma-biotech Companies: Rapid adoption for R&D
Applied Industries: Food, agriculture, and environmental testing
Other End Users: Contract research organizations
Country-Level Analysis
Australia
Australia dominates the Australia and New Zealand PCR systems market due to:
Strong healthcare and diagnostic infrastructure
Significant government investment in genomics
Large academic and research ecosystem
PCR adoption is particularly strong in clinical diagnostics, oncology research, and public health laboratories.
New Zealand
New Zealand represents a smaller but steadily growing market, driven by:
Expanding molecular diagnostic capabilities
Strong public health initiatives
Increasing research collaborations with Australia
Competitive Landscape: Key Players in the Australia and New Zealand PCR Systems Market
The market is highly competitive, with global leaders offering comprehensive PCR portfolios.
Companies Covered
Thermo Fisher Scientific Inc.
Roche Diagnostics (F. Hoffmann-La Roche Ltd)
Bio-Rad Laboratories, Inc.
QIAGEN N.V.
Agilent Technologies, Inc.
Abbott Laboratories
Danaher Corporation
bioMérieux SA
PerkinElmer, Inc.
Fluidigm Corporation
Eppendorf AG
Promega Corporation
Analytik Jena AG (Endress+Hauser Group)
Illumina, Inc.
Becton, Dickinson and Company (BD)
Key competitive strategies include:
Product innovation
Strategic partnerships with research institutes
Expansion of reagent portfolios
Local distribution and service networks
Challenges and Restraints
Despite strong growth, the market faces challenges such as:
High cost of advanced PCR systems
Need for skilled laboratory personnel
Data management and interpretation complexity
Regulatory compliance requirements
Addressing these challenges will be critical for sustained market adoption.
Future Outlook: What Lies Ahead for the Australia and New Zealand PCR Systems Market?
The future of the Australia and New Zealand PCR systems market is highly promising, supported by:
Continued growth in molecular diagnostics
Expansion of precision medicine initiatives
Advancements in digital and multiplex PCR
Integration of PCR with automation and AI-driven analytics
By 2035, PCR systems are expected to be more automated, decentralized, and application-specific, further expanding their role across healthcare and applied sciences.
See More Reports
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
